Invention Grant
- Patent Title: Formulations comprising aldosterone receptor antagonists and treatments using same
-
Application No.: US16786813Application Date: 2020-02-10
-
Publication No.: US11007203B2Publication Date: 2021-05-18
- Inventor: Salim Shah
- Applicant: Salim Shah
- Applicant Address: US VA Vienna
- Assignee: Salim Shah
- Current Assignee: Salim Shah
- Current Assignee Address: US VA Vienna
- Agency: US IP Attorneys, P.C.
- Agent Timothy Marc Shropshire
- Main IPC: A61K31/585
- IPC: A61K31/585 ; A61K9/16
Abstract:
Disclosed herein are oral dose formulations of aldosterone receptor antagonists, such as eplerenone and spironolactone, for the treatment of heart failure with preserved ejection fraction and uncontrolled hypertension.
Public/Granted literature
- US20200171054A1 FORMULATIONS COMPRISING ALDOSTERONE RECEPTOR ANTAGONISTS AND TREATMENTS USING SAME Public/Granted day:2020-06-04
Information query
IPC分类:
